of the cornea and conjunctiva [2] [3] [4] [5] [6] [7] [8] . The amniotic membrane is the innermost layer of the placenta and is a thick basal membrane with an avascular stroma [1] . The use of amniotic membrane as graft is appropriated due to its anti-inflammatory and anti-scarring effects. Amniotic membrane contains growth factors that promote epithelial wound healing on the surface of the eye, working as a basement membrane substitute or as a temporary graft [2] .
Although widely used in ophthalmic surgery, the use of sutures is time-consuming and increases tissue manipulation [2, 3] . Sutures can cause tissue trauma, potential for granuloma formation and increased surgical time. Postoperatively, it can cause foreign body sensation and its removal is discomfortable. Sutures may increase the chance of infections and when loose or unsecured should be compulsorily removed even when absorbable sutures are used [3, 4] .
Fibrin glue has been used in amniotic membrane graft and autologous conjunctival transplantation for tissue fixation. This substance is a bioadhesive material which mimics the reactions involved in the coagulation cascade promoting polymerization of fibrinogen by thrombin, which leads to the formation of clot fibrin. Thus, its application is an alternative to sutures [4, 5] .
The commercially available fibrin adhesives are constituted by two compounds which form a fibrin clot from the mixture of both. The first component is human plasma rich in fibrinogen, diluted in a solution of aprotinin. The second is a solution of thrombin and calcium chloride [5, 6] .
There is an increasing application of fibrin glue in ocular surgery. Its use has been described for closure of the conjunctiva [3] [4] [5] , glaucoma surgery [9] , trophic ulcer or perforated cornea [10] , closure of corneal and scleral tunnel, setting of autologous conjunctiva in pterygium surgery [3, 4, 11] , fixation of amniotic membrane to the sclera and cornea [6] , lamellar keratoplasty, limbal transplantation [7] and ocular surface reconstruction, but there are still few reports regarding its use in ocular surface tumor surgeries [5] . This study aims to evaluate the surgical outcomes of surface reconstruction in ocular surface tumors using fibrin sealant tissue adhesive.
Methods
This is an interventional, prospective, noncomparative study conducted in the Ocular Oncology Department of Altino Ventura Foundation, Recife, Brazil between May 2013 and February 2015. All patients with indication for surgical excision of corneal-conjunctival tumor were enrolled after signing an informed consent form. This study was approved by the Ethics Committee of the institution. Consecutive patients with indication of tumor excision were included either as primary treatment or after neoadjuvant topical chemotherapy failure. The exclusion criteria were patients with very extensive lesions, i.e. more than three quadrants of involvement of the ocular surface that required broad excision, and those with impossibility to comply with the postoperative visits.
After routine ophthalmologic evaluation, patients diagnosed with corneal-conjunctival tumors eligible for surgical treatment underwent excision of conjunctival tumor, followed by cryotherapy and reconstruction with amniotic membrane graft using fibrin glue. Patients were examined at 1, 7, 15 and 30 days postoperatively.
Surgical Technique
The surgeries were performed by the same surgeon following the routine protocol for each case. Tumor involving cornea and/ or conjunctiva was excised with a surrounding safety margin of approximately 3 mm in the conjunctiva and approximately 2 mm in the cornea followed by cryotherapy of the surgical margins. The content of one syringe was applied over the denuded sclera and the content of another syringe was applied over the amniotic membrane graft with the epithelial side facing down. Then, the membrane was flipped up to cover the sclera. Immediately, an iris spatula was used to spread the fibrin glue under the conjunctival edges.
All patients were treated with combined eye drops tobramycin 0.3% with dexamethasone 0.1% and artificial tears (sodium carmelose) within 15 days postoperatively. The following aspects were analyzed: subjective complaints, adhesiveness and positioning of the amniotic membrane graft, complications and recurrences.
Results
Twenty-five eyes from 25 patients were included, 14 of which were male and 11 female. The excised lesions were categorized according to the histological result as squamous cell neoplasia (14) , dysplasia (4), actinic keratosis (2), squamous papilloma (1) and compound melanocytic nevus (2) . In two cases, the histopathology result was negative for neoplastic cells (pterygium). Such cases were diagnosed clinically as having conjunctival dysplasia and they were treated with neoadjuvant chemotherapy. Presumably, this was the reason the sample was negative for malignant cells. Table 1 summarizes the clinical and histological data of the patients, and figure 1 shows the preand postoperative appearance of 3 patients.
Good adhesion of the amniotic membrane graft was obtained in all cases without dehiscence or graft loss. Conjunctival hyperemia was detected in all cases within the first week postoperatively. One patient presented a pinkish mass diagnosed clinically as pyogenic granuloma in a small area covered by the amniotic membrane graft, which healed after 15 days of topical steroids. Most common symptoms reported were burning and/or ocular dis- All symptoms were mild and transient, with complete resolution within a period of 7 days postoperatively. Until the 30th postoperative day, all eyes had evolved with good healing of the ocular surface. There was no clinical recurrence of the tumor in a mean time of follow-up of 11 months (range, 8-24 months).
Discussion
Amniotic membrane transplantation has been used successfully in conjunctival surface reconstruction due to its anti-inflammatory property and minimal scar formation [7, 12, 13] . Fibrin tissue adhesive has been widely applied in various medical fields, including ophthalmic surgery such as vitreoretinal, glaucoma, ocular surface, cataract and refractive surgery [3] [4] [5] [6] [7] [8] [9] [13] [14] [15] [16] [17] [18] . To our knowledge, this is one of a few reports concerning the applicability of bioadhesive in ocular surface tumor surgery [5, 15] .
Bioadhesives have the advantage of faster surgical procedure, absence of friction and tension applied to the tissues, uniform adhesion between the handled structures, more comfort, less inflammation and lower risk of tissue necrosis, infections and pyogenic granuloma formation [4, 7, 13, 17, 18] . However, its application requires speed and skill of the surgeon, due to the rapid precipitation of its components [4, 8, 13, 18] . We overcame this aspect by using the two substances separately, thus avoiding premature precipitation and difficulty to handle the graft, since this can happen when we use the two substances at once.
It is supposed that the use of biological adhesives may cause the transmission of some infectious diseases, since it is made from human or bovine fibrin, but there is no scientific evidence so far. However, no report of transmis- sion of viruses such as HIV, hepatitis B and C and Creutzfeldt-Jakob disease has been described to date [4] . The good adhesion of amniotic membrane graft in all patients and lack of graft loss in all cases indicates that the fibrin tissue adhesive was a safe and effective option in the reconstruction of the surgical area after excision of ocular surface tumors, and this is in accordance to results found in other studies [19] . A study carried out by Rubin et al. [3] showed no graft loss in two groups comparing adhesive and suture. In their study, complications occurred on the 7th day after surgery, which were a conjunctival granuloma and a retraction of the graft with a subsequent conjunctivalization [3] . In our series, we prevented scleral exposure due to occasional graft retraction pushing the graft under the conjunctival edge.
In a study involving 11 eyes with partial deficiency of limbal stem cells, all eyes maintained a stable and smooth corneal surface without recurrent erosion or persistent epithelial defect and showed less corneal opacity and neovascularization, showing that the use of fibrin tissue adhesive is safe and effective even in these cases [7] . Dal Pizzol et al. [5] , in a retrospective, noncomparative study of case series evaluating the use of fibrin glue in a wide range of ophthalmic surgical procedures, found that its use appears to be safe and effective, with low rates of complications in ocular surface surgery, cataracts and glaucoma.
It is supposed that the slighter ocular hyperemia and virtually no foreign body sensation or ocular discomfort found in this study were due to factors such as less tissue manipulation, hemostatic properties inherent to the fibrin tissue adhesive minimizing bleeding during the surgery and suture absence. Similar results were found in other studies [3-8, 11, 20] . The only complication detected was pyogenic granuloma, which was treated with corticosteroid eye drops. Is noteworthy that lower inflammation and ocular discomfort allow earlier return to work, restoring lifestyle and productivity [3] .
The study has an analytical approach limited by the lack of a control group, the small number of patients and short follow-up. However, this study will provide the basis for other upcoming studies that could confirm the findings presented here.
Conclusion
Fibrin sealant tissue adhesive can be used safely and effectively in the surgery of ocular surface tumor. In this series, sutureless amniotic membrane transplantation using fibrin glue has the potential to shorten the surgical time, mitigate inflammation postoperatively and improve patient discomfort.
